Glenmark introduces higher strength of FabiFlu to reduce pill burden of Covid-19 treatment - Times of India 07-Aug-2020

on August 07, 2020

Glenmark introduces higher strength of FabiFlu to reduce pill burden of Covid-19 treatment - Times of India

India News: MUMBAI: Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.